Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SLDB
Stock Latest News
The Fly
Solid Biosciences files to sell 1.32M shares of common stock for holders
5h ago
SLDB
Premium
The Fly
Solid Biosciences files to sell 42.78M shares of common stock for holders
5h ago
SLDB
Premium
The Fly
Solid Biosciences reports Q4 EPS (53c), consensus (52c)
6h ago
SLDB
Premium
Ratings
Buy Rating on SGT-003 Driven by Best-in-Class Efficacy Signals, Improving Safety, and Accelerated Approval Optionality
4d ago
SLDB
Premium
Pre-Earnings
SLDB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4d ago
SLDB
Premium
The Fly
Solid Biosciences price target raised to $17 from $14 at Wedbush
8d ago
SLDB
Premium
Ratings
Solid Biosciences: INSPIRE DUCHENNE Data and FDA Pathway Support Overweight/Buy Rating on SGT-003 Gene Therapy Upside
8d ago
SLDB
Premium
Company Announcements
Solid Biosciences Reports Encouraging Phase 1/2 Duchenne Data
8d ago
8K
SLDB
Premium
Ratings
Solid Biosciences: Strengthened Dystrophin Data and Emerging Cardiac Benefits Support Buy Rating on SGT-003
8d ago
SLDB
Premium
The Fly
Solid Biosciences trading resumes
8d ago
SLDB
Premium
The Fly
Solid Biosciences says interim results reinforce confidence in SGT-003 potential
8d ago
SLDB
Premium
The Fly
Solid Biosciences trading halted, news pending
8d ago
SLDB
Premium
Company Announcements
Solid Biosciences Announces $240 Million Private Placement Financing
13d ago
8K
SLDB
Premium
The Fly
Solid Biosciences prices 14.97M shares at $5.61 in private placement
14d ago
SLDB
Premium
The Fly
Solid Biosciences reaches FDA alignment on IMPACT DUCHENNE study design
1M ago
SLDB
Premium
Ratings
Reiterating Buy on Solid Biosciences: Conviction in Next‑Generation DMD Gene Therapy and Favorable Risk‑Reward
1M ago
SLDB
Premium
The Fly
Solid Biosciences participates in a conference call with William Blair
1M ago
SLDB
Premium
The Fly
Solid Biosciences participates in a conference call with Cantor
1M ago
SLDB
Premium
Ratings
Solid Biosciences: Leveraging Next-Generation Gene Therapy in DMD to Support a Buy-Rated Risk-Reward Profile
2M ago
SLDB
Premium
Ratings
Solid Biosciences: Advancing DMD Gene Therapy Toward 2026 Value Inflection With Accelerated Approval Potential
2M ago
SLDB
Premium
The Fly
FDA grants Solid Biosciences orphan drug designation for SGT-212
2M ago
SLDB
Premium
The Fly
Solid Biosciences doses first participant in Phase 1b FALCON trial on SGT-212
2M ago
SLDB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.